| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3P8Z6V53MU |
| InChI Key | AURFZBICLPNKBZ-FZCSVUEKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H34O2 |
| Molecular Weight | 318.5 |
| AlogP | 4.6 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 37.3 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 4300 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Migraine Disorders | 2 | D008881 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 11909 |
| ChEMBL | CHEMBL2057301 |
| DrugBank | DB12972 |
| FDA SRS | 3P8Z6V53MU |
| Human Metabolome Database | HMDB0001455 |
| KEGG | C15484 |
| SureChEMBL | SCHEMBL598848 |
| ZINC | ZINC000003833954 |